Immunohistochemical markers for eosinophilic esophagitis

References

• Lucendo AJ, Molina-Infante J, Arias Á, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J. 2017;5(3):335–358.
   PubMed Web of Science ®Google Scholar
• Matos LL, Trufelli DC, de Matos MG, et al. Immunohistochemistry as an important tool in biomarkers detection and clinical practice. Biomark Insights. 2010;5:9–20.
   PubMedGoogle Scholar
• Bussmann C, Schoepfer AM, Safroneeva E, et al. Comparison of different biopsy forceps models for tissue sampling in eosinophilic esophagitis. Endoscopy. 2016;48(12):1069–1075.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
   PubMed Web of Science ®Google Scholar
• Aalberse RC, Platts-Mills TA, Rispens T. The developmental history of IgE and IgG4 antibodies in relation to atopy, eosinophilic esophagitis, and the modified TH2 response. Curr Allergy Asthma Rep. 2016;16(6):45.
   PubMed Web of Science ®Google Scholar
• Clayton F, Fang JC, Gleich GJ, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 2014;147(3):602–609.
   PubMed Web of Science ®Google Scholar
• Zukerberg L, Mahadevan K, Selig M, et al. Oesophageal intrasquamous IgG4 deposits: an adjunctive marker to distinguish eosinophilic oesophagitis from reflux oesophagitis. Histopathology. 2016;68(7):968–976.
   PubMed Web of Science ®Google Scholar
• Weidlich S, Nennstiel S, Jesinghaus M, et al. IgG4 is Elevated in Eosinophilic Esophagitis but Not in Gastroesophageal Reflux Disease Patients. J Clin Gastroenterol. 2020;54(1):43–49.
   PubMed Web of Science ®Google Scholar
• Rosenberg CE, Mingler MK, Caldwell JM, et al. Esophageal IgG4 levels correlate with histopathologic and transcriptomic features in eosinophilic esophagitis. Allergy. 2018;73(9):1892–1901.
   PubMed Web of Science ®Google Scholar
• Mohammad N, Avinashi V, Chan E, et al. Pediatric eosinophilic esophagitis is associated with increased lamina propria immunoglobulin G4-positive plasma cells. J Pediatr Gastroenterol Nutr. 2018;67(2):204–209.
   PubMed Web of Science ®Google Scholar
• Ramaswamy AT, No JS, Anderson L, et al. Esophageal IgE, IgG4, and mucosal eosinophilia in individuals with dysphagia. Int Forum Allergy Rhinol. 2019;9(8):870–875.
   PubMed Web of Science ®Google Scholar
• Opriţă R, Opriţă B, Berceanu D, et al. Overview of IgG4 – related disease. J Med Life. 2017;10(4):203–207.
   PubMedGoogle Scholar
• Daniluk U, Alifier M, Kaczmarski M, et al. Longitudinal observation of children with enhanced total serum IgE. Ann Allergy Asthma Immunol. 2015;114(5):404–410.e4.
   PubMed Web of Science ®Google Scholar
• Vicario M, Blanchard C, Stringer KF, et al. Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut. 2010;59(01):12–20.
   PubMedGoogle Scholar
• Loizou D, Enav B, Komlodi-Pasztor E, et al. A pilot study of omalizumab in eosinophilic esophagitis. PLoS One. 2015;10(3):e0113483.
   PubMed Web of Science ®Google Scholar
• Muir AB, Wang JX, Nakagawa H. Epithelial-stromal crosstalk and fibrosis in eosinophilic esophagitis. J Gastroenterol. 2019;54(1):10–18.
   PubMed Web of Science ®Google Scholar
• Dellon ES, Speck O, Woodward K, et al. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study. Clin Gastroenterol Hepatol. 2014;12(12):2015–2022.
   PubMed Web of Science ®Google Scholar
• Bhattacharya B, Carlsten J, Sabo E, et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol. 2007;38(12):1744–1753.
   PubMed Web of Science ®Google Scholar
• Sato H, Nakajima N, Hasegawa G, et al. Immunohistochemical differentiation of eosinophilic esophageal myositis from eosinophilic esophagitis. J Gastroenterol Hepatol. 2017;32(1):106–113.
   PubMed Web of Science ®Google Scholar
• Kim GH, Park YS, Jung KW, et al. An increasing trend of eosinophilic esophagitis in Korea and the clinical implication of the biomarkers to determine disease activity and treatment response in eosinophilic esophagitis. J Neurogastroenterol Motil. 2019;25(4):525–533.
   PubMed Web of Science ®Google Scholar
• Cheng E, Zhang X, Huo X, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62(6):824–832.
   PubMed Web of Science ®Google Scholar
• Matoso A, Mukkada VA, Lu S, et al. Expression microarray analysis identifies novel epithelial-derived protein markers in eosinophilic esophagitis. Mod Pathol. 2013;26(5):665–676.
   PubMed Web of Science ®Google Scholar
• Hui Y, Chen S, Lombardo KA, et al. ALOX15 immunohistochemistry aids in the diagnosis of eosinophilic esophagitis on Pauci-eosinophilic biopsies in children. Pediatr Dev Pathol. 2017;20(5):375–380.
   PubMed Web of Science ®Google Scholar
• Wright BL, Nguyen N, Shim KP, et al. Increased GATA-3 and T-bet expression in eosinophilic esophagitis versus gastroesophageal reflux disease. J Allergy Clin Immunol. 2018;141(5):1919–1921.e5.
   PubMed Web of Science ®Google Scholar
• Strasser DS, Seger S, Bussmann C, et al. Eosinophilic oesophagitis: relevance of mast cell infiltration. Histopathology. 2018;73(3):454–463.
   PubMed Web of Science ®Google Scholar
• Bolton SM, Kagalwalla AF, Arva NC, et al. Mast cell infiltration is associated with persistent symptoms and endoscopic abnormalities despite resolution of eosinophilia in pediatric eosinophilic esophagitis. Am J Gastroenterol. 2020;115(2):224–233.
   PubMed Web of Science ®Google Scholar
• Merves J, Chandramouleeswaran PM, Benitez AJ, et al. Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis. PLoS One. 2015;10(2):e0114831.
   PubMed Web of Science ®Google Scholar
• Simon D, Page B, Vogel M, et al. Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis. Allergy. 2018;73(1):239–247.
   PubMed Web of Science ®Google Scholar
• Doshi A, Khamishon R, Rawson R, et al. Interleukin 9 alters epithelial barrier and E-cadherin in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2019;68(2):225–231.
   PubMed Web of Science ®Google Scholar
• Wu L, Oshima T, Li M, et al. Filaggrin and tight junction proteins are crucial for IL-13-mediated esophageal barrier dysfunction. Am J Physiol Gastrointest Liver Physiol. 2018;315(3):G341–G350.
   PubMed Web of Science ®Google Scholar
• Oshima T, Miwa H. Gastrointestinal mucosal barrier function and diseases. J Gastroenterol. 2016;51(8):768–778.
   PubMed Web of Science ®Google Scholar
• Politi E, Angelakopoulou A, Grapsa D, et al. Filaggrin and periostin expression is altered in eosinophilic esophagitis and normalized with treatment. J Pediatr Gastroenterol Nutr. 2017;65(1):47–52.
   PubMed Web of Science ®Google Scholar
• Daniluk U, Daniluk J, Guzinska-Ustymowicz K, et al. Usefulness of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in clinical characterisation of children with newly diagnosed Crohn's disease. J Paediatr Child Health. 2020;56(8):1233–1241.
   PubMed Web of Science ®Google Scholar
• Jakubowska K, Pryczynicz A, Iwanowicz P, et al. E xpressions of matrix metalloproteinases (MMP-2, MMP-7, and MMP-9) and their inhibitors (TIMP-1, TIMP-2) in inflammatory bowel diseases. Gastroenterol Res Pract. 2016;2016:2456179.
   PubMed Web of Science ®Google Scholar
• Beppu L, Yang T, Luk M, et al. MMPs-2 and -14 are elevated in eosinophilic esophagitis and reduced following topical corticosteroid therapy. J Pediatr Gastroenterol Nutr. 2015;61(2):194–199.
   PubMed Web of Science ®Google Scholar
• Filimoniuk A, Daniluk U, Samczuk P, et al. Metabolomic profiling in children with inflammatory bowel disease. Adv Med Sci. 2020;65(1):65–70.
   PubMed Web of Science ®Google Scholar
• Moye LM, Liu Y, Coarfa C, et al. Plasma urea cycle metabolites may be useful biomarkers in children with eosinophilic esophagitis. Front Pediatr. 2018;6:423.
   PubMedGoogle Scholar
• Patel DA, Higginbotham T, Slaughter JC, et al. Development and validation of a mucosal impedance contour analysis system to distinguish esophageal disorders. Gastroenterology. 2019;156(6):1617–1626.e1.
   PubMed Web of Science ®Google Scholar